Sensei Biotherapeutics Inc (NAS:SNSE)
$ 0.4792 0.0251 (5.53%) Market Cap: 11.42 Mil Enterprise Value: -31.11 Mil PE Ratio: 0 PB Ratio: 0.25 GF Score: 29/100

Sensei Biotherapeutics Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 01:30PM GMT
Release Date Price: $1.4 (-1.02%)
Russell Rudd
Jefferies - Analyst

Hello, everyone. Can everyone hear okay? I'm Russell Rudd from Jefferies healthcare banking. It's my pleasure to introduce CEO of Sensei, John Celebi. And I'll let you take it away.

John Celebi
Sensei Biotherapeutics, Inc. - President & CEO

Thanks very much, Russell, and thank you to the Jefferies team for inviting us to present at their wonderful conference. As you can probably tell from our title slide, Sensei is an immuno-oncology company. The words conditionally active are something we're going to spend a little bit of time on this morning explaining to you how our conditionally active biologics work. There are forward looking statements in this presentation.

Just to give you a little bit of background information on the company, Sensei is really focused on solving one of the key challenges in the industry today, and that is the development of therapeutics for immuno-oncology that are more finely tuned to be active within the tumor microenvironment. And the goal of that is to create better therapeutic windows

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot